Abstract
Tumor-associated chromosomal translocations lead to the formation of chimeric fusions between the EWS gene and one of five different ETS transcription factors in Ewing's family tumors (EFTs). The resultant EWS/ETS proteins promote oncogenesis in a dominant fashion in model systems and are necessary for continued growth of EFT cell lines. EWS belongs to a family of genes that encode proteins that may serve as adapters between the RNA polymerase II complex and RNA splicing factors. EWS/ETS fusions have biochemical characteristics of aberrant transcription factors and appear to promote abnormal cellular growth by transcriptionally modulating a network of target genes. Early evidence suggests that EWS/ETS proteins may also impact gene expression through alteration in RNA processing. Elucidation of EWS/ETS target gene networks in the context of other signaling pathways will hopefully lead to biology based therapeutic strategies for EFT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Athanasiou M, Clausen PA, Mavrothalassitis GJ, Zhang XK, Watson DK, Blair DG . 1996 Cell Growth Differ. 7: 1525–1534
Attwooll C, Tariq M, Harris M, Coyne JD, Telford N, Varley JM . 1999 Oncogene 18: 7599–7601
Aurias A, Rimbaut C, Buffe D, Zucker JM, Mazabraud A . 1984 Cancer Genet. Cytogenet. 12: 21–25
Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G, Ghysdael J . 1994 Mol. Cell. Biol. 14: 3230–3241
Bastian LS, Kwiatkowski BA, Breininger J, Danner S, Roth G . 1999 Blood 93: 2637–2644
Bertolotti A, Lutz Y, Heard DJ, Chambon P, Tora L . 1996 EMBO J. 15: 5022–5031
Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O, Tora L . 1998 Mol. Cell. Biol. 18: 1489–1497
Blair DG, Athanasiou M . 2000 Oncogene 19: 6472–6481
Brown LA, Rodaway AR, Schilling TF, Jowett T, Ingham PW, Patient RK, Sharrocks AD . 2000 Mech. Dev. 90: 237–252
Burchill SA, Wheeldon J, Cullinane C, Lewis IJ . 1997 Eur. J. Cancer 33: 239–243
Cavazzana AO, Miser JS, Jefferson J, Triche TJ . 1987 Am. J. Path. 127: 507–518
Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, Gusterson BA, Shipley J, Cooper CS . 1996 Oncogene 12: 229–235
Crozat A, Aman P, Mandahl N, Ron D . 1993 Nature (Lond.) 363: 640–644
Dalgleish P, Sharrocks AD . 2000 Nucleic Acids Res. 28: 560–569
Darby TG, Meissner JD, Ruhlmann A, Mueller WH, Scheibe RJ . 1997 Oncogene 15: 3067–3082
de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PH, Barr FG, Ladanyi M . 1998 J. Clin. Oncol. 16: 1248–1255
Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G . 1994 N. Engl. J. Med. 331: 294–299
Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G . 1992 Nature 359: 162–165
Deloulme JC, Prichard L, Delattre O, Storm DR . 1997 J. Biol. Chem. 272: 27369–27377
Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Roméo PH, Mignotte V . 1996 Blood 87: 4678–4685
Dhulipala PD, Lee L, Rao VN, Reddy ES . 1998 Oncogene 17: 1149–1157
Felsch JS, Lane WS, Peralta EG . 1999 Curr. Biol. 9: 485–488
Fitzsimmons D, Hodsdon W, Wheat W, Maira SM, Wasylyk B, Hagman J . 1996 Genes Dev. 10: 2198–2211
Graves BJ, Petersen JM . 1998 Adv. Cancer Res. 75: 1–55
Guinamard R, Fougereau M, Seckinger P . 1997 Scand. J. Immunol. 45: 587–595
Hahm KB . 1999 Nat. Genet. 23: 481
Hallier M, Lerga A, Barnache S, Tavitian A, Moreau-Gachelin F . 1998 J. Biol. Chem. 273: 4838–4842
Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A . 2000 Immunity 13: 167–177
Hicks GG, Singh N, Nashabi A, Mai S, Bozek G, Klewes L, Arapovic D, White EK, Koury MJ, Oltz EM, Van Kaer L, Ruley HE . 2000 Nature Genet. 24: 175–179
Ichikawa H, Shimizu K, Hayashi Y, Ohki M . 1994 Cancer Res. 54: 2865–2868
Im YH, Kim HT, Lee C, Poulin D, Welford S, Sorensen PH, Denny CT, Kim SJ . 2000 Cancer Res. 60: 1536–1540
Immanuel D, Zinszner H, Ron D . 1995 Mol. Cell. Biol. 15: 4562–4571
Jaishankar S, Zhang J, Roussel MF, Baker SJ . 1999 Oncogene 18: 5592–5597
Javelaud D, Wietzerbin J, Delattre O, Besancon F . 2000 Oncogene 19: 61–68
Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN . 1995 Oncogene 10: 1229–1234
Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F, Fujinaga K . 1996 Genes, Chrom. Cancer 15: 115–121
Knoop LL, Baker SJ . 2000 J. Biol. Chem. 275: 24865–24871
Kontny HU, Lehrnbecher TM, Chanock SJ, Mackall CL . 1998 Cancer Res. 58: 5842–5849
Kovar H, Aryee DN, Jug G, Henockl C, Schemper M, Delattre O, Thomas G, Gadner H . 1996 Cell Growth Differ. 7: 429–437
Kovar H, Dworzak M, Strehl S, Schnell E, Ambros IM, Ambros PF, Gadner H . 1990 Oncogene 5: 1067–10670
Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H . 1997 Oncogene 15: 2225–2232
Kuroda M, Sok J, Webb L, Baechtold H, Urano F, Yin Y, Chung P, de Rooij DG, Akhmedov A, Ashley T, Ron D . 2000 EMBO J. 19: 453–462
Kwiatkowski BA, Bastian LS, Bauer TR, Tsai S, Zielinska-Kwiatkowska AG, Hickstein DD . 1998 J. Biol. Chem. 273: 17525–17530
Kwiatkowski BA, Zielinska-Kwiatkowska AG, Bauer TR, Hickstein DD . 2000 Blood Cells Mol. Dis. 26: 84–90
Labelle Y, Zucman J, Stenman G, Kindblom LG, Knight J, Turc-Carel C, Dockhorn-Dworniczak B, Mandahl N, Desmaze C, Peter M, Aurias A, Delattre O, Thomas G . 1995 Hum. Mol. Gen. 4: 2219–2226
Ladanyi M, Gerald W . 1994 Cancer Res. 54: 2837–2840
Lambert G, Bertrand JR, Fattal E, Subra F, Pinto-Alphandary H, Malvy C, Auclair C, Couvreur P . 2000 Biochem. Biophys. Res. Commun. 279: 401–406
Lessnick SL, Braun BS, Denny CT, May WA . 1995 Oncogene 10: 423–431
Li R, Huiping P, Watson DK . 2000 Oncogene 19: 6514–6523
Mager AM, Grapin-Botton A, Ladjali K, Meyer D, Wolff CM, Stiegler P, Bonnin MA, Remy P . 1998 Int. J. Dev. Biol. 42: 561–572
Magnaghi-Jaulin L, Masutani H, Robin P, Lipinski M, Harel-Bellan A . 1996 Nucleic Acids Res. 24: 1052–1058
Mao X, Miesfeldt S, Yang H, Leiden JM, Thompson CB . 1994 J. Biol. Chem. 269: 18216–18222
Maroulakou IG, Bowe DB . 2000 Oncogene 19: 6432–6442
Mastrangelo T, Modena P, Tornielli S, Bullrich F, Testi MA, Mezzelani A, Radice P, Azzarelli A, Pilotti S, Croce CM, Pierotti MA, Sozzi G . 2000 Oncogene 19: 3799–3804
May WA, Arvand A, Thompson AD, Braun BS, Wright M, Denny CT . 1997 Nat. Genet. 17: 495–497
May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, Denny CT . 1993a Proc. Natl. Acad. Sci. USA 90: 5752–5756
May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R, Denny CT . 1993b Mol. Cell. Biol. 13: 7393–7398
Mélet F, Motro B, Rossi DJ, Zhang L, Bernstein A . 1996 Mol. Cell. Biol. 16: 2708–2718
Meyer D, Wolff CM, Stiegler P, Senan F, Befort N, Befort JJ, Remy P . 1993 Mech. Dev. 44: 109–121
Mitsiades N, Poulaki V, Leone A, Tsokos M . 1999 J. Natl. Cancer Inst. 91: 1678–1684
Morrison SJ, White PM, Zock C, Anderson DJ . 1999 Cell 96: 737–749
Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ES . 1994 Oncogene 9: 3087–3097
Ohno T, Rao VN, Reddy ES . 1993 Cancer Res. 53: 5859–5863
Ouchida M, Ohno T, Fujimura Y, Rao VN, Reddy ES . 1995 Oncogene 11: 1049–1054
Panagopoulos I, Hoglund M, Mertens F, Mandahl N, Mitelman F, Aman P . 1996 Oncogene 12: 489–494
Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, Ghysdael J . 1999 Oncogene 18: 1597–1608
Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR, Calabretta B . 1998 EMBO J. 17: 4442–4455
Perrotti D, Iervolino A, Cesi V, Cirinna M, Lombardini S, Grassilli E, Bonatti S, Claudio PP, Calabretta B . 2000 Mol. Cell. Biol. 20: 6159–6169
Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H, Delattre O . 1997 Oncogene 14: 1159–1164
Petermann R, Mossier BM, Aryee DN, Khazak V, Golemis EA, Kovar H . 1998 Oncogene 17: 603–610
Powers CA, Mathur M, Raaka BM, Ron D, Samuels HH . 1998 Mol. Endocrin. 12: 4–18
Prasad DD, Ouchida M, Lee L, Rao VN, Reddy ES . 1994 Oncogene 9: 3717–3729
Rabbitts TH, Forster A, Larson R, Nathan P . 1993 Nature Gen. 4: 175–180
Rao VN, Ohno T, Prasad DD, Bhattacharya G, Reddy ES . 1993 Oncogene 8: 2167–2173
Rauscher FJ, Benjamin LE, Fredericks WJ, Morris JF . 1994 Cold Spring Harb. Symp. Quant. Biol. 59: 137–146
Sancéau J, Hiscott J, Delattre O, Wietzerbin J . 2000 Oncogene 19: 3372–3383
Sarrazin S, Starck J, Gonnet C, Doubeikovski A, Melet F, Morle F . 2000 Mol. Cell. Biol. 20: 2959–2969
Scotlandi K, Baldini N, Cerisano V, Manara MC, Benini S, Serra M, Lollini PL, Nanni P, Nicoletti G, Bernard G, Bernard A, Picci P . 2000a Cancer Res. 60: 5134–5142
Scotlandi K, Chano T, Benini S, Serra M, Manara MC, Cerisano V, Picci P, Baldini N . 2000b Intl. J. Cancer 87: 328–335
Sjögren H, Meis-Kindblom J, Kindblom LG, Aman P, Stenman G . 1999 Cancer Res. 59: 5064–5067
Sohn HW, Choi EY, Kim SH, Lee IS, Chung DH, Sung UA, Hwang DH, Cho SS, Jun BH, Jang JJ, Chi JG, Park SH . 1998 Am. J. Path. 153: 1937–1945
Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT . 1994 Nat. Genet. 6: 146–151
Sorensen PH, Shimada H, Liu XF, Lim JF, Thomas G, Triche TJ . 1995 Cancer Res. 55: 1385–1392
Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK . 2000 Mol. Cell. Biol. 20: 5643–5652
Stolow DT, Haynes SR . 1995 Nucleic Acids Res. 23: 835–843
Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E, Reis M, Ben-David Y . 1999 Mol. Cell. Biol. 19: 4452–4464
Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y . 1997 J. Clin. Invest. 99: 239–247
Teitell MA, Thompson AD, Sorensen PH, Shimada H, Triche TJ, Denny CT . 1999 Lab. Invest. 79: 1535–1543
Thompson AD, Teitell MA, Arvand A, Denny CT . 1999 Oncogene 18: 5506–5513
Thorner P, Squire J, Chilton-MacNeil S, Marrano P, Bayani J, Malkin D, Greenberg M, Lorenzana A, Zielenska M . 1996 Am. J. Pathol. 148: 1125–1138
Triche TJ, Askin FB, Kissane JM . 1987 Major Problems in Pathology Vol. 18. Feingold M. and Bennington JC (eds) Saunders: Philadelphia pp. 145–195
Truong AHL, Ben-David Y . 2000 Oncogene 19: 6482–6489
Turc-Carel C, Philip I, Berger MP, Philip T, Lenoir GM . 1984 Cancer Gen. Cytogen. 12: 1–19
Urano F, Umezawa A, Hong W, Kikuchi H, Hata J . 1996 Biochem. Biophys. Res. Commun. 219: 608–612
Watson DK, Robinson L, Hodge DR, Kola I, Papas TS, Seth A . 1997 Oncogene 14: 213–221
Watson DK, Seth A . 2000 Oncogene 55: 6393–6547
Wei G, Antonescu CR, de Alava E, Leung D, Huvos AG, Meyers PA, Healey JH, Ladanyi M . 2000 Cancer 89: 793–799
Yang L, Chansky HA, Hickstein DD . 2000a J. Biol. Chem. 275: 37612–37618
Yang L, Embree LJ, Hickstein DD . 2000b Mol. Cell. Biol. 20: 3345–3354
Yang L, Embree LJ, Tsai S, Hickstein DD . 1998 J. Biol. Chem. 273: 27761–27764
Zhang L, Eddy A, Teng YT, Fritzler M, Kluppel M, Melet F, Bernstein A . 1995 Mol. Cell. Biol. 15: 6961–6970
Zinszner H, Albalat R, Ron D . 1994 Genes Dev. 8: 2513–2526
Zinszner H, Sok J, Immanuel D, Yin Y, Ron D . 1997 J. Cell. Sci. 110: 1741–1750
Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer-Menz I, Smith TL, Jurgens H, Gadner H, Kovar H . 1996 J. Clin. Oncol. 14: 1245–1251
Zoubek A, Pfleiderer C, Salzer-Kuntschik M, Amann G, Windhager R, Fink FM, Koscielniak E, Delattre O, Strehl S, Ambros PF, Gadner H, Kovar H . 1994 Br. J. Cancer 70: 908–913
Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletchers CD, Aurias A, Thomas G . 1993a Nature Gen. 4: 341–345
Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O . 1993b EMBO J. 12: 4481–4487
Zwerner JP, May WA . 2001 Oncogene 20: 626–633
Acknowledgements
This work is supported through the National Institutes of Health grant RO1-87771.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arvand, A., Denny, C. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20, 5747–5754 (2001). https://doi.org/10.1038/sj.onc.1204598
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204598
Keywords
This article is cited by
-
Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells
Cancer Gene Therapy (2023)
-
Liquid–liquid phase separation drives cellular function and dysfunction in cancer
Nature Reviews Cancer (2022)
-
Maligne Rundzelltumoren
Der Pathologe (2020)
-
Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis
Journal of Molecular Medicine (2019)
-
Case report of an ewing’s sarcoma/primitive neuroectodermal tumor of the kidney
International Urology and Nephrology (2018)